BANK OF AMERICA CORP /DE/ - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$258,975
-85.7%
102,362
-62.2%
0.00%
Q2 2023$1,804,807
-71.6%
270,992
-20.5%
0.00%
-100.0%
Q1 2023$6,361,660
+154.5%
340,925
+193.0%
0.00%
Q4 2022$2,499,433
+71.3%
116,361
-5.7%
0.00%
Q3 2022$1,459,000
-20.3%
123,457
-11.0%
0.00%
Q2 2022$1,831,000
-55.2%
138,763
-29.0%
0.00%
Q1 2022$4,085,000
+42.5%
195,363
+38.6%
0.00%
Q4 2021$2,866,000
+48.3%
140,985
+121.3%
0.00%
Q3 2021$1,933,000
-15.7%
63,709
-19.2%
0.00%
Q2 2021$2,292,000
-35.5%
78,891
-4.1%
0.00%
Q1 2021$3,551,000
+14.4%
82,291
+22.5%
0.00%
Q4 2020$3,105,000
+13.5%
67,199
+6.5%
0.00%
Q3 2020$2,735,000
+10.8%
63,092
+35.6%
0.00%
Q2 2020$2,468,000
+3696.9%
46,544
+1512.2%
0.00%
Q1 2020$65,000
+71.1%
2,887
+11.3%
0.00%
Q4 2019$38,0000.0%2,593
-51.4%
0.00%
Q3 2019$38,000
+171.4%
5,334
+344.9%
0.00%
Q2 2019$14,000
-33.3%
1,199
-42.8%
0.00%
Q1 2019$21,000
+2000.0%
2,096
+980.4%
0.00%
Q3 2018$1,000
-88.9%
194
-77.3%
0.00%
Q1 2018$9,0008550.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders